A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation

Nicotinic  7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex

(2013) Y. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neural Correlates of Stress- and Food Cue-Induced Food Craving in Obesity: Association with insulin levels

(2012) A. M. Jastreboff et al.   DIABETES CARE

Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings

(2012) Helen C Fox et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation

(2012) S. A. McKee et al.   NICOTINE & TOBACCO RESEARCH

Reward, Addiction, Withdrawal to Nicotine

(2011) Mariella De Biasi et al.   Annual Review of Neuroscience

Memory modulation.

(2011) Benno Roozendaal et al.   BEHAVIORAL NEUROSCIENCE

A preliminary study of the neural effects of behavioral therapy for substance use disorders

(2011) Elise E. DeVito et al.   DRUG AND ALCOHOL DEPENDENCE

Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: Altered working memory and BOLD response

(2011) Thomas W. McAllister et al.   INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY

Effects of α-2A adrenergic receptor agonist on time and risk preference in primates

(2011) Soyoun Kim et al.   PSYCHOPHARMACOLOGY

Cognitive mechanisms underlying relapse to nicotine

(2011) Robin A.J. Lester   REVIEWS IN THE NEUROSCIENCES

Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence

(2010) Amy C. Janes et al.   BIOLOGICAL PSYCHIATRY

The α2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats

(2010) Svetlana Semenova et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder

(2010) Amy FT Arnsten   Expert Review of Neurotherapeutics

Stress decreases the ability to resist smoking and potentiates smoking intensity and reward

(2010) Sherry A McKee et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats

(2010) Hidetaka Yamada et al.   NEUROPHARMACOLOGY

Erratum: Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction

(2010) Benoit Forget et al.   NEUROPSYCHOPHARMACOLOGY

Prefrontal-striatal pathway underlies cognitive regulation of craving

(2010) H. Kober et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats

(2010) Adrie W. Bruijnzeel et al.   PSYCHOPHARMACOLOGY

Chronic Stress, Drug Use, and Vulnerability to Addiction

(2009) Rajita Sinha   Annals of the New York Academy of Sciences

Stress signalling pathways that impair prefrontal cortex structure and function

(2009) Amy F. T. Arnsten   NATURE REVIEWS NEUROSCIENCE

Involvement of α1-adrenoceptors in conditioned place preference supported by nicotine in rats

(2009) Benoît Forget et al.   PSYCHOPHARMACOLOGY

Pretreatment Brain Activation During Stroop Task Is Associated with Outcomes in Cocaine-Dependent Patients

(2008) Judson A. Brewer et al.   BIOLOGICAL PSYCHIATRY

Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction

(2008) B. J Everitt et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES